Eyre, T. A., Lamanna, N., Roeker, L. E., Ujjani, C. S., Hill, B. T., Barr, P. M., Lansigan, E., Cheson, B. D., Yazdy, M., Allan, J. N., Rhodes, J., Schuster, S. J., Nabhan, C., Skarbnik, A., Leslie, L., Islam, P., Whitaker, K., Coombs, C. C., Tuncer, H. H., Pagel, J. M., Jacobs, R., Winter, A. M., Bailey, N., Sitlinger, A., Schuh, A. H., Follows, G., Fox, C. P., Brander, D. M., Shadman, M. and Mato, A. R. (2020) “Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia”, Haematologica. Pavia, Italy, 106(1), pp. 284-287. doi: 10.3324/haematol.2019.241539.